Estrella Immunopharma Inc - Warrants (29/09/2028)
ESLAW - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.44M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.44 Million |
|---|---|
| Enterprise Value | $3.29 Million |
| Earnings per Share | $-0.35 |
| Beta | -0.09 |
| Outstanding Shares | 42,997,733 |
Return
| Return on Equity | 134.74% |
|---|---|
| Return on Assets | -548.74% |
| Return on Invested Capital | 130.29% |
Valuation & Multiples
| P/E Ratio | -2.6 |
|---|---|
| PEG | 4.45 |
| Price to Sales | - |
| Price to Book Ratio | -0.08 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.34 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$-0.09
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$-0.08
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 30,0000% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.15%▼ 0.02% |
|---|---|
| Total Invested | $64,505▲ 73.56% |
| Investors Holding | 90% |